From PvP Biologics Raises $35M in a Lab-to-Pharma Deal with Takeda:

KumaMax Enzyme (Image by Vikram Mulligan:Univ. Wash., used with permission)
KumaMax Enzyme (Image by Vikram Mulligan:Univ. Wash., used with permission)

Computer-generated image of KumaMax Enzyme (Image by Vikram Mulligan:Univ. Wash., used with permission)